Overview

Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to examine the effect of coadministration of CYP3A4 inhibitors on the pharmacokinetics of AZD9742.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Cytochrome P-450 CYP3A Inhibitors
Diltiazem
Ketoconazole